TY - JOUR
T1 - Treating anxiety disorders in older adults
T2 - Current treatments and future directions
AU - Bower, Emily S.
AU - Wetherell, Julie Loebach
AU - Mon, Thetsu
AU - Lenze, Eric J.
N1 - Publisher Copyright:
© Lippincott Williams & Wilkins.
PY - 2015/9/19
Y1 - 2015/9/19
N2 - Anxiety disorders are highly prevalent among the elderly and are associated with increased disability, poor quality of life, and cognitive impairment. Despite this high prevalence and associated morbidities, anxiety disorders in late life are underreported and understudied. In this article, we discuss the epidemiology, disease presentation, and current treatment of anxiety disorders in older adults. We also discuss limitations in the current understanding of such disorders in this population, as well as future research directions that may reveal the mechanisms and rationale for treatment regimens for anxiety disorders in late life. We present material on the application of the Research Domain Criteria (RDoC) model to geriatric anxiety. Finally, we describe optimal management strategies of anxiety disorders.
AB - Anxiety disorders are highly prevalent among the elderly and are associated with increased disability, poor quality of life, and cognitive impairment. Despite this high prevalence and associated morbidities, anxiety disorders in late life are underreported and understudied. In this article, we discuss the epidemiology, disease presentation, and current treatment of anxiety disorders in older adults. We also discuss limitations in the current understanding of such disorders in this population, as well as future research directions that may reveal the mechanisms and rationale for treatment regimens for anxiety disorders in late life. We present material on the application of the Research Domain Criteria (RDoC) model to geriatric anxiety. Finally, we describe optimal management strategies of anxiety disorders.
KW - anxiety
KW - geriatric
KW - late life
UR - http://www.scopus.com/inward/record.url?scp=84942032000&partnerID=8YFLogxK
U2 - 10.1097/HRP.0000000000000064
DO - 10.1097/HRP.0000000000000064
M3 - Review article
C2 - 26332216
AN - SCOPUS:84942032000
SN - 1067-3229
VL - 23
SP - 329
EP - 342
JO - Harvard review of psychiatry
JF - Harvard review of psychiatry
IS - 5
ER -